These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lymphokine-activated effector cells: modulation of activity by cytokines. Mehta S; Flanagan P; Blackinton D; Wanebo H Lymphokine Cytokine Res; 1992 Apr; 11(2):73-7. PubMed ID: 1581419 [TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma (IFN-gamma) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity--IFN-gamma-induced suppressive activity. Toledano M; Mathiot C; Michon J; Andreu G; Lando D; Brandely M; Fridman WH Cancer Immunol Immunother; 1989; 30(1):57-64. PubMed ID: 2513112 [TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant interferon-gamma and interleukin-2 on the generation of lymphokine-activated killer cells in vitro. Findley HW; Nasr S; Afify Z; Hnath R; Waldrep K; Ragab AH Cancer Invest; 1990; 8(5):493-500. PubMed ID: 2124946 [TBL] [Abstract][Full Text] [Related]
7. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors. Mulé JJ; Krosnick JA; Rosenberg SA J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444 [TBL] [Abstract][Full Text] [Related]
8. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity. Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715 [TBL] [Abstract][Full Text] [Related]
9. Growth of MCF-7 human breast carcinoma in severe combined immunodeficient mice: growth suppression by recombinant interleukin-2 treatment and role of lymphokine-activated killer cells. Zhai YF; Esselman WJ; Oakley CS; Chang CC; Welsch CW Cancer Immunol Immunother; 1992; 35(4):237-45. PubMed ID: 1511458 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of murine lymphokine-activated killer cell activity by retinoic acid. Lin TH; Chu TM Cancer Res; 1990 May; 50(10):3013-8. PubMed ID: 1970751 [TBL] [Abstract][Full Text] [Related]
11. Differences in murine gut-associated lymphoid tissues in generating broadly nonspecific cytotoxic cells in response to interferon alpha A/D and interleukin 2. Chikkala NF; Gautam SC Cell Immunol; 1991 Jul; 135(2):418-30. PubMed ID: 2036676 [TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 from macrophages of murine splenocyte cultures inhibits the generation of lymphokine-activated killer cell activity. Ohnishi H; Lin TH; Nakajima I; Chu TM Tumour Biol; 1991; 12(2):99-110. PubMed ID: 2028183 [TBL] [Abstract][Full Text] [Related]
13. Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity. Vujanovic NL; Herberman RB; Hiserodt JC Cancer Res; 1988 Feb; 48(4):878-83. PubMed ID: 3257411 [TBL] [Abstract][Full Text] [Related]
15. Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiers. Nio Y; Zighelboim J; Berek JS; Bonavida B Nat Immun Cell Growth Regul; 1990; 9(4):283-96. PubMed ID: 2215516 [TBL] [Abstract][Full Text] [Related]
16. Soluble factors produced by macrophages/monocytes inhibit lymphokine-activated killer activity in rat splenocyte cultures. Kuppen PJ; Eggermont AM; Quak RB; Marinelli A; van de Velde CJ; Fleuren GJ Cancer Immunol Immunother; 1994 Jan; 38(1):61-7. PubMed ID: 8299120 [TBL] [Abstract][Full Text] [Related]
17. Effect of IFN-gamma treatment and in vivo passage of murine tumor cell lines on their sensitivity to lymphokine-activated killer (LAK) cell lysis in vitro; association with H-2 expression on the target cells. Tsai L; Ohlén C; Ljunggren HG; Kärre K; Hansson M; Kiessling R Int J Cancer; 1989 Oct; 44(4):669-74. PubMed ID: 2507452 [TBL] [Abstract][Full Text] [Related]
18. Lysis of human solid tumor cells by lymphokine-activated natural killer cells. Itoh K; Tilden AB; Balch CM J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648 [TBL] [Abstract][Full Text] [Related]
19. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells. Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622 [TBL] [Abstract][Full Text] [Related]
20. Acidic polysaccharide from Panax ginseng, ginsan, induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2. Kim KH; Lee YS; Jung IS; Park SY; Chung HY; Lee IR; Yun YS Planta Med; 1998 Mar; 64(2):110-5. PubMed ID: 9525101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]